Friday, November 25, 2016

SCHOTT’s Fiber Optic Faceplates

SCHOTT technology is advancing digital X-rays for hospitals and clinics, scientific labs, and defense and transportation applications. With the company’s fiber optic faceplates, X-ray technicians are able to reduce radiation doses while still generating sharp and clear images with less noise. The international technology group will exhibit these materials at the Radiological Society of North America’s Scientific Assembly and Annual Meeting, held Nov. 27 to Dec. 2 at Chicago’s McCormick Place (booth #1902, South Hall A).

By protecting a digital X-ray’s complementary metal oxide semiconductor (CMOS) sensors, SCHOTT’s RoHS-compliant large format fiber optic faceplates help produce higher-quality images with lower doses of radiation. The company produces these plates in conformity with ISO9001:2008 and ISO13485:2003 standards; all of SCHOTT’s Lighting and Imaging facilities are ISO certified.

SCHOTT’s faceplates allow for high resolution images through high X-ray absorption and contrast, and are manufactured as large as 320 mm x 320 mm. These fused fiber optic faceplates integrate fiber optic elements ranging from 6 microns in diameter to 25 microns or larger.

“Digital X-ray imaging demands faster speeds and higher dosage levels, but too much radiation can create noise and ultimately damage sensitive CMOS detectors,” said Jeff Lowe, Senior Project Manager, Medical at SCHOTT. “The integration of fiber optic faceplates into CMOS detectors has allowed for significantly improved image resolution, which ultimately helps to improve the patient experience.”


SCHOTT ( is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions.  They are an innovative enabler for many industries, including the home appliance, pharmaceutical, electronics, optics, automotive and aviation industries. The group maintains a global presence with production sites and sales offices in 35 countries. With its workforce of approximately 15,000 employees, sales of $2.24 billion were generated in fiscal year 2014/2015.

Monday, November 21, 2016

MACOM Announces Definitive Agreement to Acquire AppliedMicro

Deal to Accelerate and Broaden Breakout in Cloud Data Centers; MACOM Intends to Divest Compute Business within 100 Days of Closing

LOWELL, Mass., November 21, 2016 - MACOM Technology Solutions Holdings, Inc.  (NASDAQ: MTSI) (“MACOM”), a leading supplier of high-performance analog RF, microwave, millimeterwave and photonic semiconductor products, today announced it has entered into a definitive agreement to acquire Applied Micro Circuits Corporation (NASDAQ:AMCC) (“AppliedMicro”), a global leader in Connectivity and Computing solutions for next-generation cloud infrastructure and Data Centers, for approximately $8.36 per share, consisting of $3.25 in cash and 0.1089 MACOM shares per share of AppliedMicro. This price for each share of AppliedMicro represented a 15.4% premium over the company’s closing price of $7.25 on Friday, November 18th.  MACOM intends to divest the well-positioned but non-strategic Compute business within the first 100 days of closing.

Transaction Highlights Include:

  • Transaction valued at approximately $770 million for AppliedMicro’s approximately $165 million in TTM revenue (including the Compute business) and $82 million of cash and short-term investments at September 30, 2016
  • MACOM and AppliedMicro’s pro forma combined TTM revenue was approximately $709 million including AppliedMicro’s Compute business, or approximately $644 million excluding the Compute business
  • AppliedMicro’s Connectivity business is highly complementary to MACOM’s product portfolio, through the addition of market-leading OTN framers, MACsec Ethernet networking components and the industry’s leading single-lambda PAM4 platform
  • Transaction to accelerate MACOM’s significant growth in optical technologies for Cloud Service Providers and Enterprise Network customers serving the high-growth, high-margin Data Center market
  • AppliedMicro’s leadership PAM4 solutions based on FinFET technology and custom engagements with top-tier Data Center and service provider customers is expected to strengthen MACOM’s competitive position with those customers
  • MACOM expects to improve the profitability of AppliedMicro by divesting the Compute business and by delivering on substantial revenue and cost synergies
  • Excluding the Compute business, MACOM expects this transaction to be accretive to its non-GAAP gross margin, non-GAAP operating margin and non-GAAP EPS, in MACOM’s fiscal year ending September, 2017
  • MACOM to benefit from over $600 million of tax net operating loss carry forwards

Commenting on the transaction, John Croteau, President and Chief Executive Officer, stated, "This transaction will accelerate and expand MACOM’s breakout opportunity in Enterprise and Cloud Data Centers. MACOM will now be able to provide all the requisite semiconductor content for optical networks - analog, photonic and PHY - from the switch to fiber for long haul, metro, access, backhaul and Data Center. AppliedMicro’s 100G to 400G single-lambda PAM4 platform should perfectly complement MACOM's leadership in analog and photonic components for Data Centers.

“Notably, the IEEE recently recommended the adoption of AppliedMicro’s single lambda PAM4 solution to be an industry standard for enterprise and Data Center connectivity, positioning this technology as the solution of choice going forward. Additionally, AppliedMicro’s Connectivity business aligns well with MACOM's differentiated, high-growth business model, offering non-GAAP gross margins well in excess of MACOM’s long term target operating model, long product life cycles, and sticky customer relationships.”

“AppliedMicro also provides value-added technologies including SerDes, high speed analog-to-digital and digital-to-analog converters with industry-leading engineering competencies and long product lifecycles. Importantly, we expect that this transaction will establish MACOM with an incumbent position supplying strategic components and enterprise and cloud Data Center customers.”

MACOM intends to divest AppliedMicro’s well-positioned Compute business within 100 days from closing the transaction, as the business does not strategically align with MACOM’s long-term focus.  AppliedMicro has been exploring strategic options for the Compute business and there is known strategic interest among several potential buyers and investors. MACOM will continue to support Compute customers and partners during this transition.

“This is an exciting day for AppliedMicro, and we are pleased to be joining forces with MACOM.  The transaction affirms the value that our employees have created and provides a strong path forward for our Connectivity business while delivering AppliedMicro stockholders a robust premium,” said Paramesh Gopi, President and CEO, AppliedMicro.  “This transaction will create an industry powerhouse with the scale, deep customer relationships, innovative technology, and enabling products that will help deliver explosive growth in Enterprise and Cloud Data Centers.  In addition, this agreement provides a promising path forward for the Compute business, which is in the process of bringing AppliedMicro’s highly-competitive third-generation X-Gene processor to market.  X-Gene is well-positioned to address the large opportunity for mainstream server processors with its proven high performance cores, scalable interconnect and high per socket memory capabilities.”

MACOM intends to commence a tender offer to purchase each outstanding common share of AppliedMicro for approximately $8.36 per share, consisting of $3.25 in cash and 0.1089 MACOM shares per share of AppliedMicro. MACOM will assume certain equity awards held by AppliedMicro employees. The transaction value is approximately $770 million in diluted equity value, or approximately $688 million net of AppliedMicro’s cash position of approximately $82 million as of September 30, 2016. The transaction is expected to be accretive to MACOM's non-GAAP gross margin, non-GAAP operating margin and non-GAAP EPS in fiscal year 2017, excluding the Compute business. AppliedMicro stockholders are expected to own approximately 15% of the combined company on a pro forma basis. MACOM expects to pay the cash portion of the acquisition price from cash on hand. The boards of directors of both companies have approved the transaction, which is subject to customary closing conditions and regulatory approvals. MACOM currently expects the transaction to close in the first calendar quarter of 2017.

Evercore is acting as exclusive financial advisor and Ropes & Gray LLP is serving as legal counsel to MACOM.

Morgan Stanley & Co. LLC  is acting as exclusive financial advisor and Pillsbury Winthrop Shaw Pittman LLP is serving as legal counsel to AppliedMicro. The board of directors of AppliedMicro received a fairness opinion from Morgan Stanley & Co. LLC  and Needham & Company, LLC.


MACOM enables a better-connected and safer world by delivering breakthrough semiconductor technologies for optical, wireless and satellite networks that satisfy society’s insatiable demand for information.

Today, MACOM powers the infrastructure that millions of lives and livelihoods depend on every minute to communicate, transact business, travel, stay informed, and be entertained. Our technology increases the speed and coverage of the mobile Internet and enables fiber optic networks to carry previously unimaginable volumes of traffic to businesses, homes, and datacenters.

Keeping us all safe, MACOM technology enables next-generation radars for air traffic control and weather forecasting, as well as mission success on the modern networked battlefield.

MACOM is the partner of choice to the world’s leading communications infrastructure, aerospace and defense companies, helping solve their most complex challenges in areas including network capacity, signal coverage, energy efficiency, and field reliability, through its best-in-class team and broad portfolio of analog RF, microwave, millimeterwave, and photonic semiconductor products.

MACOM is a pillar of the semiconductor industry, thriving for more than 60 years of daring to change the world for the better, through bold technological strokes that deliver true competitive advantage to customers and superior value to investors.

Headquartered in Lowell, Massachusetts, MACOM is certified to the ISO9001 international quality standard and ISO14001 environmental management standard. MACOM has design centers and sales offices throughout North America, Europe, Asia and Australia.

MACOM, M/A-COM, M/A-COM Technology Solutions, M/A-COM Tech, Partners in RF & Microwave, and related logos are trademarks of MACOM. All other trademarks are the property of their respective owners. For more information about MACOM, please visit follow @MACOMtweets on Twitter, join MACOM on LinkedIn, or visit the MACOM YouTube Channel.

About AppliedMicro

AppliedMicro Circuits Corporation (Nasdaq:AMCC) is a global leader in computing and connectivity solutions for next-generation cloud infrastructure and data centers. AppliedMicro delivers silicon solutions that dramatically lower total cost of ownership. Corporate headquarters are located in Santa Clara, California.

Wednesday, November 16, 2016



Quebec City, Quebec, November 16, 2016 – Opsens Inc. (“Opsens”) (TSXV:OPS) (OTCQX:OPSSF) today reported its results for the year ended August 31, 2016.


  • The OptoWire II, Opsens’ guidewire to measure Fractional Flow Reserve ("FFR") has been authorized for sale in the U.S., Europe, Japan and Canada;

  • FFR product sales

  • FFR revenues were $2.1 million in the fourth quarter of 2016 compared with $0.3 million in the corresponding quarter of 2015;

  • FFR revenues were $5.2 million for fiscal 2016 compared with $0.5 million in fiscal 2015;

  • The performance of the OptoWire was highlighted in Circulation Journal, a recognized medical publication;

  • Opsens extended its range of applications with 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the OptoMonitor II, a monitor combining the ability to measure FFR along with measuring intravascular and intracatheter pressure.


Opsens’ commercial channels are demonstrating success from quarter to quarter, with Q4 revenues up more than 600% compared with the fourth quarter of the previous year. "We are confident that the distinctive features of the OptoWire, widely recognized by key opinion leaders in interventional cardiology, will allow us to capitalize on the rapidly growing FFR market," said Louis Laflamme, President and Chief Executive Officer of Opsens.

"Our move into a modern facility and the ongoing production process improvement will enhance our competitiveness and our ability to meet the growing demand for our products. We are taking the necessary measures to become a disruptive player in the industry. For 2017, we are targeting significant gains in global market share," concluded Mr. Laflamme.


The performance of Opsens’ OptoWire was highlighted in the Circulation Journal, the official journal of the Japanese Circulation Society. The article reports that the use of approximately 100 OptoWire units was performed without any drift of the measurement and also mentions the shortcomings in the performance of competitive products in terms of reliability of the measurement.


Opsens’ revenues were higher for the year ended August 31, 2016 at $9.6 million compared with $8.7 million in 2015. This revenue increase reflects higher revenues in FFR of $4.7 million, partly offset by a decrease of $3.4 million from non-recurring revenues recorded in 2015 from distribution rights. 

Corporate overview

Since 2003, Opsens has stood for innovative strength, a passion for technology and uncompromising commitment to quality and excellence. Pioneer in the fiber optic sensing technology, we seek to provide solutions to industries which can benefit from the advantages that our technology provides. To tap their business opportunities in both new and established markets, they organised their Company into three sectors: Medical, Energy and Industry.